Visual loss in sarcoid-related uveitis
- PMID: 12880455
- DOI: 10.1046/j.1442-9071.2003.00666.x
Visual loss in sarcoid-related uveitis
Abstract
Purpose: To assess the visual acuity outcome after treatment, in patients with differing types of uveitis associated with sarcoidosis, and to determine the types of sight-threatening complications.
Methods: This was an retrospective, non-comparative, interventional study of patients who had uveitis with a confirmed diagnosis of sarcoidosis and a minimum follow-up duration of 6 months from presentation. The worst affected eye at presentation was selected for the study. Complications causing impaired vision were documented, changes in visual acuity after completion of treatment were measured, and the risk of 'poor outcome' (visual acuity 6/12 and less) was compared in the various types of uveitis, using 'exact' multiple logistic regression to control confounding by other prognostic factors.
Results: Seventy-five patients were studied. The spectrum of ocular inflammation in sarcoidosis is wide. Presentation may be acute and non-granulomatous or chronic and granulomatous with posterior segment involvement being varied. Poor visual outcome was significantly more frequent in multifocal choroiditis (5/7, 71.4%), and in panuveitis without multifocal choroiditis (13/28, 46.4%), compared to only 3/24 (12.5%) patients with anterior uveitis. The excess risks remained significant after adjustment for confounding effects of other prognostic factors including age, sex and manifest systemic sarcoidosis. Causes of visual loss were cataract, glaucoma, macular oedema, vitreous haemorrhage and retinal detachment.
Conclusion: Multifocal choroiditis is a less common manifestation of uveitis associated with sarcoidosis but appears to be associated with a worse visual prognosis despite immunosuppressive therapy.
Similar articles
-
Prognosticators for visual outcome in sarcoid uveitis.Ophthalmology. 1996 Nov;103(11):1846-53. doi: 10.1016/s0161-6420(96)30417-x. Ophthalmology. 1996. PMID: 8942880
-
Visual outcome in ocular sarcoidosis: retrospective evaluation of risk factors.Eur J Ophthalmol. 2011 Nov-Dec;21(6):802-10. doi: 10.5301/EJO.2011.6417. Eur J Ophthalmol. 2011. PMID: 21374555
-
Anti-TNF-α therapy in refractory uveitis associated with sarcoidosis: Multicenter study of 17 patients.Semin Arthritis Rheum. 2015 Dec;45(3):361-8. doi: 10.1016/j.semarthrit.2015.05.010. Epub 2015 May 21. Semin Arthritis Rheum. 2015. PMID: 26092330
-
[Sarcoid uveitis: Ophthalmologist's and internist's viewpoints].Rev Med Interne. 2023 Mar;44(3):112-122. doi: 10.1016/j.revmed.2022.10.001. Epub 2023 Jan 13. Rev Med Interne. 2023. PMID: 36642624 Review. French.
-
Sarcoid Uveitis: An Intriguing Challenger.Medicina (Kaunas). 2022 Jul 4;58(7):898. doi: 10.3390/medicina58070898. Medicina (Kaunas). 2022. PMID: 35888617 Free PMC article. Review.
Cited by
-
Conjunctival Impression Cytology and Tear Film Changes in Sarcoidosis: A Subjective and Objective Diagnosis Study.Turk J Ophthalmol. 2023 Aug 19;53(4):200-205. doi: 10.4274/tjo.galenos.2022.58153. Turk J Ophthalmol. 2023. PMID: 37602549 Free PMC article.
-
Sarcoidosis-Related Uveitis: A Review.J Clin Med. 2023 Apr 29;12(9):3194. doi: 10.3390/jcm12093194. J Clin Med. 2023. PMID: 37176633 Free PMC article. Review.
-
Clinical features and visual outcomes of ocular sarcoidosis at a tertiary referral center in Tokyo.Graefes Arch Clin Exp Ophthalmol. 2022 Oct;260(10):3357-3363. doi: 10.1007/s00417-022-05701-x. Epub 2022 May 26. Graefes Arch Clin Exp Ophthalmol. 2022. PMID: 35616725
-
Ocular sarcoidosis prevalence and clinical features in the Northern Ireland population.Eye (Lond). 2022 Oct;36(10):1918-1923. doi: 10.1038/s41433-021-01770-0. Epub 2021 Sep 23. Eye (Lond). 2022. PMID: 34556818 Free PMC article.
-
Microangiopathy in Ocular Sarcoidosis Using Fluorescein Gonio and Fundus Angiography from Diagnostic and Therapeutic Aspects.Diagnostics (Basel). 2020 Dec 28;11(1):39. doi: 10.3390/diagnostics11010039. Diagnostics (Basel). 2020. PMID: 33379396 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical